20:02 EST Cathie Wood’s ARK Investment buys 653K shares of Recursion Pharmaceuticals (RXRX) today
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXRX:
- Recursion Pharmaceuticals price target lowered to $10 from $12 at KeyBanc
- Recursion announces two oncology drugs advancing to clinical trials
- Recursion Pharmaceuticals price target lowered to $10 from $12 at BofA
- Recursion Pharmaceuticals CFO Ben Taylor to Join Exscientia
- Recursion Pharmaceuticals call volume above normal and directionally bullish